A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma.
about
A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A UK feasibility and validatio ...... ations in metastatic melanoma.
@en
A UK feasibility and validatio ...... ations in metastatic melanoma.
@nl
type
label
A UK feasibility and validatio ...... ations in metastatic melanoma.
@en
A UK feasibility and validatio ...... ations in metastatic melanoma.
@nl
prefLabel
A UK feasibility and validatio ...... ations in metastatic melanoma.
@en
A UK feasibility and validatio ...... ations in metastatic melanoma.
@nl
P2093
P2860
P356
P1476
A UK feasibility and validatio ...... tations in metastatic melanoma
@en
P2093
Anna Paterson
Jane Maraka
Jennifer Garioch
Jenny Nobes
Joseph Goodwill
Laszlo Igali
Michelle Chin I Lo
Richard Clark
P2860
P2888
P304
P356
10.1038/BJC.2016.106
P407
P577
2016-06-23T00:00:00Z